Smoking, Stress, HIV and Mobile Technology (NCT05709002) | Clinical Trial Compass
CompletedNot Applicable
Smoking, Stress, HIV and Mobile Technology
United States76 participantsStarted 2023-10-16
Plain-language summary
The present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating information specifically relevant to Black persons with HIV/AIDS. (2) To conduct a randomized clinical trial for anxiety-sensitivity reduction and cigarette cessation among Black smokers with HIV.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* HIV-infection (via self-report and picture of medication, lab tests, or diagnosis)
* 18+ years of age
* Self-identify as Black / African American
* Daily smoking (minimum of 10 cigarettes per day on average for at least 2 years)
* Motivated to quit smoking (≥ 5 on a 10-point scale)
* Willingness to discontinue cigarette use two weeks after baseline visit.
* English literacy (score of 4 or greater on REALM-SF)
* Moderate to high anxiety sensitivity (score of 5 or greater on SSASI)
* Provide a current picture of their cigarette package to verify smoking status
* Willing to complete all study surveys/assessments
* Agree to use nicotine replacement medications (NRT; nicotine patch and lozenges)
* Agree to attempt to quit smoking two weeks after completion of the baseline survey and receipt of study materials
Exclusion Criteria:
* Actively receiving (ongoing) pharmacotherapy or psychotherapy directly focused on the treatment of smoking cessation, and/or substance use, not provided by the study
* Non-fluent/limited English proficiency
* Self-reported pregnancy or intentions to become pregnant in near future
* Legal status that would interfere with participation
* Being non-Black
* Cognitive impairment (assessed via the 6-item Cognitive Impairment Test)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.